Glucagon-Like Peptide-2 in the Control of Gastrointestinal Motility: Physiological Implications

被引:10
|
作者
Baccari, Maria Caterina [1 ]
Vannucchi, Maria Giuliana
Idrizaj, Eglantina [1 ]
机构
[1] Univ Florence, Sect Physiol Sci, Dept Expt & Clin Med, Viale GB Morgagni 63, I-50134 Florence, Italy
关键词
Glucagon-like peptide-2; acetylcholine; gastrointestinal motility; neuromodulation; nitric oxide; substance P; vasoactive intestinal peptide; VASOACTIVE-INTESTINAL-PEPTIDE; GLP-2 RECEPTOR EXPRESSION; NITRIC-OXIDE; ENTERIC NEURONS; LIPID ABSORPTION; IN-VIVO; RELAXIN; LOCALIZATION; NO; NEUROTRANSMISSION;
D O I
10.2174/1389203723666220217142935
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Glucagon-Like Peptide-2 (GLP-2) is a pleiotropic hormone that plays several roles in different organs and tissues, so being involved in many physiological processes. Among these, it regulates gastrointestinal (GI) tract function binding to a specific G-protein coupled receptor (GLP-2R). Of note, GLP-2R is widely expressed in different cells of the GI tract, including excitatory and inhibitory neurons of the enteric nervous system. In the gut, GLP-2 has been reported to play numerous actions, among which the modulation of motility. Nevertheless, most of the GLP-2 effects and its role in physiological processes are still debated. The aim of this minireview is to summarize the data present in the literature on the control of GI motility by GLP-2, the mechanism through which it occurs, and to discuss the physiological implications of such effects. A better understanding of the role of GLP-2 on GI motor responses may be of importance for the development of new therapeutic approaches in GI dysmotility.
引用
收藏
页码:61 / 69
页数:9
相关论文
共 50 条
  • [21] In vivo and in vitro degradation of glucagon-like peptide-2 in humans
    Hartmann, B
    Harr, MB
    Jeppesen, PB
    Wojdemann, M
    Deacon, CF
    Mortensen, PB
    Holst, JJ
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (08): : 2884 - 2888
  • [22] Physiology and Pharmacology of the Enteroendocrine Hormone Glucagon-Like Peptide-2
    Drucker, Daniel J.
    Yusta, Bernardo
    ANNUAL REVIEW OF PHYSIOLOGY, VOL 76, 2014, 76 : 561 - 583
  • [23] Glucagon-like Peptide-2 and the Regulation of Intestinal Growth and Function
    Brubaker, Patricia L.
    COMPREHENSIVE PHYSIOLOGY, 2018, 8 (03) : 1185 - 1210
  • [24] Glucagon-like peptide-2 increases BDNF expression in glia
    Yoshitake, Yumiko
    Iwai, Takashi
    Oka, Jun-Ichiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109 : 124P - 124P
  • [25] Distribution of glucagon-like peptide-2 in normal colonic tissue
    Caddy, G
    Johnston, C
    Ardill, J
    Pogue, K
    Collins, J
    Gardiner, K
    Watson, P
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2003, 38 (07) : 798 - 799
  • [26] Therapeutic potential of the intestinotropic hormone, glucagon-like peptide-2
    L'Heureux, MC
    Brubaker, PL
    ANNALS OF MEDICINE, 2001, 33 (04) : 229 - 235
  • [27] Plasma glucagon-like peptide-2 in cats with chronic enteropathies
    Jugan, Maria C.
    Plattner, Brandon L.
    Ford, Alexandra K.
    Freilich, Leah
    Bieberly, Zackery
    Schermerhorn, Thomas
    JOURNAL OF FELINE MEDICINE AND SURGERY, 2025, 27 (01)
  • [28] Current and potential therapeutic targets of glucagon-like peptide-2
    Austin, Kaori
    Markovic, Melanie A.
    Brubaker, Patricia L.
    CURRENT OPINION IN PHARMACOLOGY, 2016, 31 : 13 - 18
  • [29] Structure, measurement, and secretion of human glucagon-like peptide-2
    Hartmann, B
    Johnsen, AH
    Orskov, C
    Adelhorst, K
    Thim, L
    Holst, JJ
    PEPTIDES, 2000, 21 (01) : 73 - 80
  • [30] Localization of Glucagon-Like Peptide-2 Receptor Expression in the Mouse
    Yusta, Bernardo
    Matthews, Dianne
    Koehler, Jacqueline A.
    Pujadas, Gemma
    Kaur, Kiran Deep
    Drucker, Daniel J.
    ENDOCRINOLOGY, 2019, 160 (08) : 1950 - 1963